ArticleTherapeutic advances in neurological disorders2021

High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients.

Christopher M Dwyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.